Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for December 7th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 7th:

Aviat Networks, Inc. (AVNW - Free Report) : This wireless networking products, solutions, and services provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18% over the last 60 days.

 

Aviat Networks’ shares gained 69.2% over the last one month compared with the S&P 500’s growth of 5.2%. The company possesses a Momentum Score of A.

 

Micron Technology, Inc. (MU - Free Report) : This memory and storage products manufacturer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.3% over the last 60 days.

 

Micron Technology’s shares gained 32.5% over the last one month. The company possesses a Momentum Score of A.

 

Hillenbrand, Inc. (HI - Free Report) : This diversified industrial company a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.8% over the last 60 days.

 

Hillenbrand Inc Price and Consensus

Hillenbrand Inc Price and Consensus

Hillenbrand Inc price-consensus-chart | Hillenbrand Inc Quote

 

Hillenbrand’s shares gained nearly 30% over the last one month. The company possesses a Momentum Score of A.

 

NetApp, Inc. (NTAP - Free Report) : This software, systems, and services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 16% over the last 60 days.

 

NetApp, Inc. Price and Consensus

NetApp, Inc. Price and Consensus

NetApp, Inc. price-consensus-chart | NetApp, Inc. Quote

 

NetApp’s shares gained 29.3% over the last one month. The company possesses a Momentum Score of A.

 

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in